Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 5/2015

01-05-2015 | Original Paper

Profiles of Risk Among HIV-Infected Youth in Clinic Settings

Authors: M. Isabel Fernández, Heather C. Huszti, Patrick A. Wilson, Shoshana Kahana, Sharon Nichols, René Gonin, Jiahong Xu, Bill G. Kapogiannis

Published in: AIDS and Behavior | Issue 5/2015

Login to get access

Abstract

Despite the rising number of new HIV infections among youth, few tailored interventions for youth living with HIV (YLH) have been developed and rigorously tested. Developing tailored interventions necessitates identifying different profiles of YLH and understanding how risk and protective factors cluster together. Obtaining this critical information requires accessing a sufficiently large sample of YLH from diverse geographic settings such as those available through the Adolescent Trials Network for HIV Interventions (ATN). We recruited a cross-sectional sample of 1,712 YLH from ATN clinics; participants completed a survey on psychosocial and health factors. Using latent class analysis on nine composite variables representing risk factors, we identified five classes distinguished by substance use, sexual behavior, and pregnancy history and differing on health outcomes. Findings suggest a need for tailored interventions addressing multiple risky behaviors of HIV-infected youth and research to clarify how intervention effectiveness may differ by risk profile.
Literature
1.
Arnett JJ. Emerging adulthood. A theory of development from the late teens through the twenties. Am Psychol. 2000;55(5):469–80.CrossRefPubMed
2.
3.
Phillips G II, Wohl A, Xavier J, Jones K, Hidalgo J. Epidemiologic data on young men of color who have sex with men. AIDS Patient Care STDS. 2011;25(Suppl 1):S3–8.CrossRefPubMed
4.
Marshall K, Crepaz N, O’Leary A. A systematic review of evidence-based behavioral interventions for African American youth at risk for HIV/STI infection, 1988-2007. In: McCree DH, et al., editors. African Americans and HIV/AIDS. New York: Springer; 2010. p. 151–80.CrossRef
5.
Robin L, Dittus P, Whitaker D, et al. Behavioral interventions to reduce incidence of HIV, STD, and pregnancy among adolescents: a decade in review. J Adolesc Health. 2004;34(1):3–26.CrossRefPubMed
6.
Leonard AD, Markham CM, Bui T, Shegog R, Paul ME. Lowering the risk of secondary HIV transmission: insights from HIV-positive youth and health care providers. Perspect Sex Reprod Health. 2010;42(2):110–6.CrossRefPubMedCentralPubMed
7.
Reisner SL, Mimiaga MJ, Skeer M, Perkovich B, Johnson CV, Safren SA. A review of HIV antiretroviral adherence and intervention studies among HIV-infected youth. Top HIV Med. 2009;17(1):14–25.PubMedCentralPubMed
8.
9.
Naar-King S, Wright K, Parsons JT, et al. Healthy choices: motivational enhancement therapy for health risk behaviors in HIV-positive youth. AIDS Educ Prev. 2006;18(1):1–11.CrossRefPubMed
10.
Chen X, Murphy DA, Naar-King S, Parsons JT, Adolescent Medicine Trials Network for HIV, AIDS Intervention. A clinic-based motivational intervention improves condom use among subgroups of youth living with HIV. J Adolesc Health. 2011;49(2):193–8.CrossRefPubMedCentralPubMed
11.
Rotheram-Borus MJ, Murphy DA, Kennedy M, Stanton A, Kuklinski M. Health and risk behaviors over time among youth living with HIV. J Adolesc. 2001;24(6):791–802.CrossRefPubMed
12.
Murphy DA, Durako SJ, Mosicki AB, et al. No change in health risk behaviors over time among HIV infected adolescents in care: role of psychological distress. J Adolesc Health. 2001;29(3 Suppl):57–63.CrossRefPubMed
13.
Kadivar H, Garvie PA, Sinnock C, Heston JD, Flynn PM. Psychosocial profile of HIV-infected adolescents in a Southern US Urban cohort. AIDS Care. 2006;18(6):544–9.CrossRefPubMed
14.
Centers for Disease Control and Prevention. Vials signs: HIV infection, testing, and risk behaviors among youths—United States. MMWR Morb Mortal Wkly Rep. 2012;61(47):971–6.
15.
Metsch LR, Pereyra M, Messinger S, et al. HIV transmission risk behaviors among HIV-infected persons who are successfully linked to care. Clin Infect Dis. 2008;47(4):577–84.CrossRefPubMed
16.
Stein JA, Rotheram-Borus MJ, Swendeman D, Milburn NG. Predictors of sexual transmission risk behaviors among HIV-positive young men. AIDS Care. 2005;17(4):433–42.CrossRefPubMedCentralPubMed
17.
Di Risio M, Ballantyne PJ, Read SE, Bendayan R. “HIV isn’t me…”: HIV+ adolescents experiences in a positive context of support and treatment. Aids Care. 2011;23(6):694–9.CrossRefPubMed
18.
Charmaz K. The body, identity, and self: adapting to impairment. Sociol Q. 1995;36(4):657–80.CrossRef
19.
20.
Derogatis LR, Melisaratos N. The brief symptom inventory: an introductory report. Psychol Med. 1983;13(3):595–605.CrossRefPubMed
21.
Humeniuk R, Henry-Edwards S, Ali R, Poznyak V, Monteiro MG, Organization WH. Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): manual for use in primary care. Geneva: World Health Organization; 2010.
22.
Knight JR, Sherritt L, Shrier LA, Harris SK, Chang G. Validity of the CRAFFT substance abuse screening test among adolescent clinic patients. Arch Pediatr Adolesc Med. 2002;156(6):607–14.CrossRefPubMed
23.
Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000;12(3):255–66.CrossRefPubMed
24.
Collins LM, Lanza ST. Latent class and latent transition analysis: with applications in the social, behavioral, and health sciences. New York: Wiley; 2010.
25.
Gaughan DM, Hughes MD, Oleske JM, et al. Psychiatric hospitalizations among children and youths with human immunodeficiency virus infection. Pediatrics. 2004;113(6):e544–51.CrossRefPubMed
26.
Misdrahi D, Vila G, Funk-Brentan I, Tardieu M, Blanche S, Mouren-Simeoni MC. DSM-IV mental disorders and neurological complications in children and adolescents with human immunodeficiency virus type 1 infection (HIV-1). Eur Psychiatry. 2004;19(3):182–4.CrossRefPubMed
27.
Pao M, Lyon M, D’Angelo LJ, et al. Psychiatric diagnoses in adolescents seropositive for the human immunodeficiency virus. Arch Pediatr Adolesc Med. 2000;154(3):240–4.CrossRefPubMed
28.
Mulligan K, Harris DR, Emmanuel P, et al. Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network protocol 021b. In: 18th Conference on retroviruses and opportunistic infections. Boston, March 2011.
29.
Havens PL, Hazra R, Stephensen C, et al. Vitamin D3 supplementation decreases parathyroid hormone (PTH) in HIV-infected youth being treated with tenofovir-containing combination antiretroviral therapy: a randomized, double-blind, placebo-controlled multicenter trial: Adolescent Trials Network protocol 063. In: 18th Conference on retroviruses and opportunistic infections. Boston, March 2011.
30.
CDC. Youth risk behavior surveillance—United States, 2007. MMWR. 2008;57(SS04):1–131.
31.
Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med. 2005;352(1):48–62.CrossRefPubMed
32.
Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC Jr. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med. 1997;337(19):1343–9.CrossRefPubMed
33.
34.
Clifford GM, Lise M, Franceschi S, et al. Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. Br J Cancer. 2012;106(3):447–52.CrossRefPubMedCentralPubMed
35.
Burns DN, Hillman D, Neaton JD, et al. Cigarette smoking, bacterial pneumonia, and other clinical outcomes in HIV-1 infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13(4):374–83.CrossRefPubMed
36.
Conley LJ, Bush TJ, Buchbinder SP, Penley KA, Judson FN, Holmberg SD. The association between cigarette smoking and selected HIV-related medical conditions. AIDS. 1996;10(10):1121–6.PubMed
37.
38.
Hirani A, Cavallazzi R, Vasu T, et al. Prevalence of obstructive lung disease in HIV population: a cross sectional study. Respir Med. 2011;105(11):1655–61.CrossRefPubMed
39.
Treisman GJ, Angelino AF, Hutton HE. Psychiatric issues in the management of patients with HIV infection. JAMA. 2001;286(22):2857–64.CrossRefPubMed
40.
41.
42.
43.
44.
Sherbourne CD, Hays RD, Fleishman JA, et al. Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiatry. 2000;157(2):248–54.CrossRefPubMed
45.
Tucker JS, Orlando M, Burnam MA, Sherbourne CD, Kung FY, Gifford AL. Psychosocial mediators of antiretroviral nonadherence in HIV-positive adults with substance use and mental health problems. Health Psychol. 2004;23(4):363–70.CrossRefPubMed
46.
McGowan JP, Shah SS, Ganea CE, et al. Risk behavior for transmission of Human Immunodeficiency Virus (HIV) among HIV-seropositive individuals in an urban setting. Clin Infect Dis. 2004;1(38):122–7.CrossRef
47.
Klinkenberg WD, Sacks S, HIV/AIDS Treatment Adherence, Health Outcomes and Cost Study Group. Mental disorders and drug abuse in persons living with HIV/AIDS. AIDS Care. 2004;16(Suppl 1):S22–42.CrossRefPubMed
48.
(SAMHSA), C.f.S.A.T., Substance Abuse Treatment for Persons With Co-Occurring Disorders, C.f.S.A. Treatment, editors. Rockville: Substance Abuse and Mental Health Services Administration; 2005.
49.
Sherer R, Stieglitz K, Narra J, et al. HIV multidisciplinary teams work: support services improve access to and retention in HIV primary care. AIDS Care. 2002;14(Suppl 1):S31–44.CrossRefPubMed
50.
Lo W, MacGovern T, Bradford J. Association of ancillary services with primary care utilization and retention for patients with HIV/AIDS. AIDS Care. 2002;14(Suppl 1):S45–57.CrossRefPubMed
51.
Magnus M, Schmidt N, Kirkhart K, et al. Association between ancillary services and clinical and behavioral outcomes among HIV-infected women. AIDS Patient Care STDS. 2001;15(3):137–45.CrossRefPubMed
52.
Metzger DS, Koblin B, Turner C, et al. Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. Am J Epidemiol. 2000;152(2):99–106.CrossRefPubMed
53.
Nichols SL, Lowe A, Zhang X, et al. Concordance between self-reported substance use and toxicology among HIV-infected and uninfected at risk youth. Drug Alcohol Depend. 2014;1(134):376–82.CrossRef
Metadata
Title
Profiles of Risk Among HIV-Infected Youth in Clinic Settings
Authors
M. Isabel Fernández
Heather C. Huszti
Patrick A. Wilson
Shoshana Kahana
Sharon Nichols
René Gonin
Jiahong Xu
Bill G. Kapogiannis
Publication date
01-05-2015
Publisher
Springer US
Published in
AIDS and Behavior / Issue 5/2015
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-014-0876-y

Other articles of this Issue 5/2015

AIDS and Behavior 5/2015 Go to the issue

Original Paper

Individual-Level and Partner-Level Predictors of Newly Diagnosed HIV Infection Among Black and White Men Who Have Sex with Men in Baltimore, MD

Original Paper

Understanding Concerns About Treatment-as-Prevention Among People with HIV who are not Using Antiretroviral Therapy

Original Paper

Prescription Drug Misuse and Sexual Risk Behaviors Among Young Men Who have Sex with Men (YMSM) in Philadelphia

Original Paper

Knowledge is Power! Increased Provider Knowledge Scores Regarding Pre-exposure Prophylaxis (PrEP) are Associated with Higher Rates of PrEP Prescription and Future Intent to Prescribe PrEP

Original Paper

Communication About Microbicide Use Between Couples in KwaZulu-Natal, South Africa

Original Paper

The Demand for Antiretroviral Drugs in the Illicit Marketplace: Implications for HIV Disease Management Among Vulnerable Populations

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits